ZEJULA 300 mg/1

ZEJULA 300 mg is a prescription medication containing niraparib, used for specific therapeutic purposes. This oral tablet is designed to support targeted treatment regimens as directed by healthcare professionals.

ZEJULA 300 mg tablets are primarily used in the management of certain conditions related to DNA repair mechanisms. Niraparib, the active ingredient, is often utilized in maintenance therapy for patients who have responded to prior treatment. The medication is prescribed to help maintain treatment effects and manage symptoms associated with these conditions.

Common effects of ZEJULA 300 mg may include fatigue, nausea, and changes in blood cell counts. Some individuals might experience gastrointestinal discomfort or other mild to moderate symptoms. It is important to discuss any persistent or severe effects with a healthcare provider.

ZEJULA 300 mg should be handled with care, following the instructions provided by a healthcare professional. It is essential to store the medication properly and adhere to the prescribed regimen. Patients should inform their healthcare provider about any existing medical conditions or other medications they are taking.

ZEJULA 300 mg may interact with certain medications, including those that affect liver enzymes or blood cell production. It is important to avoid alcohol and discuss all current medications with a healthcare provider to prevent potential interactions. Always follow professional advice regarding the use of niraparib.